Purpose: The prevalence of endometrial cancer (EC) is increasing worldwide. Progestin therapy is effective for both early stage EC patients who require preserving fertility and advanced or recurrent patients. Progestin resistance resulting from downregulation of progesterone receptor (PR) remains a major problem, and its mechanism is currently unclear. It was demonstrated that Sirtuin 1 (SIRT1), forkhead transcription factor 1 (FoxO1) and sterol regulatory element binding protein-1 (SREBP-1) may act as a pathway and play crucial roles in the development of EC in our previous studies. In the present study, we investigated the effect on the development of progestin resistance and the relationship with PR of SIRT1/FoxO1/SREBP-1.

Methods: A progestin-resistant Ishikawa cell line was established in the stimulation and selection of medroxyprogesterone acetate (MPA), and the resistance was analyzed by MTT assay, flow cytometry, and Transwell invasion assay. qRT-PCR and western blotting were conducted to detect the expression of SIRT1, FoxO1, SREBP-1 and PR. SIRT1 knockdown progestin-resistant cells were established by lentiviral transduction.

Results: The new progestin-resistant cell line presented sufficient resistance to MPA in aspects of proliferation, distribution of cell cycle and apoptosis compared with original Ishikawa cells. Besides, the invasion capability of progestin-resistant cells was observably increased. In both protein and mRNA levels, SIRT1 and SREBP-1 were upregulated in progestin-resistant cells, while PR and FoxO1 were downregulated. SIRT1 was knocked down by lentivirus transfection in progestin-resistant cells, resulting in upregulation of PR, FoxO1 and downregulation of SREBP-1, thereby SIRT1 knockdown cells were more sensitive to MPA compared with progestin-resistant cells.

Conclusion: SIRT1/FoxO1/SREBP-1 act as a pathway targeting PR and involve in the development of progestin resistance in Ishikawa cells.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00404-018-4893-3DOI Listing

Publication Analysis

Top Keywords

progestin resistance
16
progestin-resistant cells
16
development progestin
12
endometrial cancer
8
srebp-1 sirt1
8
sirt1 knockdown
8
ishikawa cells
8
progestin-resistant
7
cells
7
resistance
6

Similar Publications

Acupuncture and traditional Chinese medicine (TCM) have shown certain benefits in assisted in vitro fertilization and embryo transfer (IVF-ET). In this study, we evaluated the efficacy and safety of the combination of acupuncture combined with the Bushen Quyu decoction in patients with failures of IVF-ET. This study was conducted at Shanghai Yangpu District Hospital of TCM from May to November of 2021.

View Article and Find Full Text PDF
Article Synopsis
  • Metabolic syndrome (MS) negatively impacts reproductive health in female mice, leading to issues like disrupted estrous cycles and impaired reproductive success.
  • In the study, mice on a high-fat diet showed signs of MS, such as insulin resistance and hormonal imbalances, which affected their endometrial health and reproductive outcomes.
  • Treatment with metformin improved these reproductive issues by normalizing hormone levels and restoring proper endometrial function, suggesting potential benefits for women with MS seeking to enhance reproductive health.
View Article and Find Full Text PDF
Article Synopsis
  • - Levels of progesterone increase after ovulation and are vital for supporting pregnancy, but gut microbiota can influence these levels by affecting the hormone's recycling in the liver and gut.
  • - A specific gut bacterium plays a key role in metabolizing progesterone into a neurosteroid, which does not have progestogenic activity; researchers identified the enzyme responsible for this conversion.
  • - In experiments with female mice, certain antibiotics helped restore progesterone levels, and prolonged antibiotic use disrupted ovarian follicle development, suggesting a link between gut bacteria and progesterone resistance in women.
View Article and Find Full Text PDF

Weight-Loss and Metformin-Use Improve the Reversal Rate in Patients with Endometrial Hyperplasia.

Int J Womens Health

November 2024

Department of Gynecology and Obstetrics, Tianjin Medical University General Hospital, Tianjin, 300052, People's Republic of China.

Objective: To evaluate the therapeutic outcomes of weight loss and metformin use in patients with endometrial hyperplasia (EH), and to identify the factors influencing treatment efficacy.

Methods: This study included data from patients diagnosed with either EH or endometrial atypical hyperplasia (EAH). Patients selected a progestin treatment regimen based on their diagnosis.

View Article and Find Full Text PDF
Article Synopsis
  • Endometriosis affects about 10% of women of reproductive age and leads to issues like chronic pain and dysmenorrhea, impacting overall quality of life.
  • The main treatments focus on pain management and fertility preservation, often using hormonal therapies and assisted reproductive technologies (ART) such as IVF.
  • Recent studies suggest that IAP (inhibitor of apoptotic protein) inhibitors and other compounds like parthenolide may offer new therapeutic options by targeting the inflammatory processes involved in endometriosis.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!